Q1 Venture Capital Results

April 25, 2011

Venture investments in Q1 2011 increased by $1 billion over Q4 2010 to $7.5 billion. The increase was driven by an increase in investments in Internet and cleantech-renewable energy startups, according to CB Insights.

This was a 25% increase in the number of dollars invested over the same period last year. The money was spread of 738 deal, which is approximately the same as last year.

This represents a return to the pre-recession levels. The CB Insights “left it to others to decide whether that represents a return to normalcy or an untenable VC investment bubble.”

1 Comment | commentary, news release, Venture capital, yet2.com, yet2Ventures | Tagged: , , , , , , , | Permalink
Posted by bendupont

yet2.com Webinar – April 21st – Improve deal-making process

April 19, 2011


Join us to hear how experienced deal-makers are succeeding, at our upcoming webinar:

Conference Preview: Successful Deal-making with Small Companies April 21, 2011, 11:00am EST.

We’ll be discussing relationship building, cross-cultural appreciation, ongoing consulting, and step-wise deal structures, among other topics. We’ve gathered representatives from both the small and big company perspectives to share their thoughts — tune in to learn how you can hasten and improve your own deal process.

Webinar speakers:

Steve Baggott, Director, External Business Development, Procter & Gamble
Robert Michelson, President, Butler Home Products
Dr. Greg Williams, Director of Research and Development, Monteco Ltd.

April’s webinar is an exclusive preview of a live panel discussion to be held at yet2.com’s upcoming Open Innovation conference in May, in Boston.

Register today for the Successful Deal-making with Small Companies Preview Webinar here:

https://www2.gotomeeting.com/register/311188682

Leave a Comment » | commentary, news release, Uncategorized, yet2.com, yet2Ventures | Tagged: , , , , , , | Permalink
Posted by bendupont

Ganeden Biotech Launches Probiotic Yogurt at Walmart

February 21, 2011
Ganeden Biotech is a yet2ventures portfolio company – Ben
/PRNewswire/ — Today, a new low-cost, all-natural yogurt branded as enLiven (www.enlivenyogurt.com) launches exclusively in Walmart stores. The low-fat yogurt from Ganeden, the nation’s leading distributor of over-the-counter probiotic products, is available in four delicious flavors and features GanedenBC30 probiotics.

“Yogurt has long been touted as a healthy breakfast and snack food,” said Carl Freund, vice president of consumer products at Ganeden. “We believe Walmart shoppers will enjoy our tasty new enLiven yogurt with beneficial probiotics, as it is not only good for you and your whole family, but it is affordably priced to help save you money.”

Read the rest of this entry »

2 Comments | news release, Venture capital, yet2.com, yet2Ventures | Tagged: , , , , , | Permalink
Posted by bendupont

yet2.com Open Innovation Conference, Boston, May 17th to 19th

February 10, 2011

yet2.com hosts a fantastic Open Innovation conference annually.  Typically more than 50 of the Fortune 500 participate.  It’s a very active hands on event.  Key speakers are from; P&G, DSM, DuPont, Tyco, Colgate- Ben

PS  Previously, our speakers have included; Dean Kamen, Dr. Oz, Henry Chesbrough, Esther Dyson, etc.

The event is an intimate technology scouting and networking conference for executive Open Innovation, technology, R&D, licensing, and business leaders. Recent conferences have averaged 120–140 leaders representing 100+ global corporations from six continents. Big enough to be global, small enough to encourage meaningful conversation.

This year the event will be held May 17-19th at the Hyatt Regency Cambridge, MASS USA.

Speakers include:

Dr. Kenneth W. Klimpel, Worldwide Director – External Innovation, Colgate Palmolive, Stephen J. Baggott, Director, Global Business Development, Procter & Gamble, Jim Toth, PhD, Sr. Director of Technology Strategy, Tyco Electronics, Marcel Lubben, Managing Director, DSM Venturing and DSM Licensing, and Michael T. Kane, Founder, Fairbridge Venture Partners.

Past attendees include: Agfa, Amway, Ashland, AT&T, Bayer, BP, Catepillar, Ciba, DSM, DuPont, Eastman Chemical, GE, Georgia-Pacific, W.L. Gore, Honeywell, IBM, Microsoft, NASA, Northrop Grumman, P&G, Royal Dutch Shell, Samsung, SAP, Tyco,Unilever, Wrigley.

A complete list of speakers and past attendees can be found here.

Leave a Comment » | news release, open innovation, Venture capital, yet2.com, yet2Ventures | Tagged: , , , , , , , | Permalink
Posted by bendupont

Ganeden Biotech’s Strain of Probiotics Proves Very Effective

January 25, 2011

Ganeden Biotech is a yet2Ventures portfolio company – Ben

New Study Catalogues Evidence for Probiotic, Bacillus coagulans

Review paper supports multiple health claims for specific Bacillus coagulans strain, GanedenBC30®

Cleveland (PRWEB) January 25, 2011

A new paper examining recent research and safety data published in the peer-reviewed journal Food Science and Technology Bulletin provides scientific support for Bacillus coagulans as a probiotic. The overview supports the use of probiotics in general and discusses a specific Bacillus coagulans strain, known as GanedenBC30 (Bacillus coagulans GBI-30, 6086), manufactured by consumer healthcare company Ganeden Biotech, for its probiotic attributes. The study summarizes how GanedenBC30 supports its health claims related to safety, gastrointestinal health, immune health, joint health and includes never before published data.

“Probiotic strains have been traditionally limited to Lactobacillus and Bifidobacterium,” explained Dr. Glenn Gibson, one of the world’s leading probiotic experts and co-author of the paper. “The evaluation of this recent data shows great promise for Bacillus coagulans as a new type of probiotic that’s come to the forefront.” Read the rest of this entry »

1 Comment | news release, Venture capital, yet2.com, yet2Ventures | Tagged: , , , , , , | Permalink
Posted by bendupont

yet2.com forms yet2Ventures investment fund and teams up with Japan’s JAIC

January 24, 2011

Tokyo, Japan and Boston, MA USA, 24 January 2011 — yet2.com has formed yet2Ventures, a fund created to help Fortune 500 firms and other owners of venture capital investments drive value in their portfolio companies. We can provide follow-on investment and liquidity to help small companies grow. We are excited about this effort and believe yet2.com is uniquely positioned to help portfolio companies grow with:

  • Our global network, with offices in Tokyo, Boston, Liverpool, and Wilmington
  • Our IP experience
  • Our technology licensing experience
  • And, now our capital

Venture funding is an excellent fit with the established yet2.com market, where we help large and small companies connect on new and robust technologies.

Our first joint investment with JAIC is in Avantis Medical Systems of Sunnyvale, California. They develop and manufacture catheter-based endoscopic devices for detecting and treating cancer in the GI tract.

The yet2Ventures fund is a good partnership opportunity for VC firms and other strategic investors. Perhaps we can help your portfolio grow, too? Please contact us at:venturefund@yet2.com.

About JAIC

Japan Asia Investment Co., Ltd. (JAIC) is an independent venture capital company founded in 1981 by the Japan Association of Corporate Executives (Keizai Doyukai). JAIC’s operations are centered on three geographic hubs — Japan, Asia, and the United States. In these regions, JAIC provides financial support for companies in various stages of development from promising venture enterprises to companies with succession or business reorganization needs, or firms looking to revitalize their businesses. In addition, JAIC seeks to stimulate growth and raise the corporate value of invested companies by providing support on the management side as well. These include supplying information, consulting for initial public offerings (IPO), and business matching.

About yet2.com

yet2.com provides intellectual property consulting and licensing services to world-class clients around the globe. Yet2.com Inc and its online marketplace were founded in 1999 to promote Open Innovation, with original investments from Siemens, Bayer, Honeywell, DuPont, Procter & Gamble, Caterpillar, and NTT Leasing. The privately held company has offices in the United States, Europe, and Japan. The web site now has over 120,000 registered marketplace users including many of the Fortune 500 and over 16,000 smaller technology companies. In addition to its core team, yet2.com has created a wide network of Open Innovation partners covering many of the technology-rich countries around the world as well as relationships with open innovation organizations, technical expert networks, SME networks, technical magazines, online technical communities, and technology brokers. These provide market-wide access to technologies and needs in countries such as Russia, China, India, Korea, Brazil, South Africa, Japan, the US, and the EU. For more information, visit www.yet2.com or contact Tim Bernstein 1-781-972-0600.

 

1 Comment | news release, open innovation, yet2.com, yet2Ventures | Tagged: , , , , | Permalink
Posted by bendupont

Calling Cutting Edge Technologists for Tech Competition!

January 20, 2011

We’re seeking innovative technologies in 4 categories for yet2.com’s new Step2Change Technology Competition. Finalists receive promotional services as well as presentation opportunity to 100+ senior executive technology scouts from the Global 1000!

In partnership with NASA Tech Briefs, Clean 15, RadTech and yet2 Ventures, the competition is designed to connect exciting technology companies in four leading areas to the commercial market: 1) Sustainable Packaging; 2) Materials—lighter/stronger/better/cleaner; 3) Consumer home/health medical devices; and 4) Electronics.

yet2.com’s Step2Change Technology Competition is organized in conjunction with yet2.com’s annual Executive Briefing conference, to take place in Boston in May, 2011.

Competition finalists will gain ACCESS TO:
• Unparalleled Cross-section of the Global 1000 International Partners and Markets
• Sources of Capital
• Joint Ventures/Licensing Opportunities
• Increased Deal Flow

Our goal is to connect leading edge technologies to the partners and capital necessary to accelerate their access to the global market.
Submissions due March 15, 2011!

Let us connect you! Don’t miss this unique access to the Global 1000!

Learn more and apply here!

Leave a Comment » | news release, yet2.com | Permalink
Posted by bendupont

yet2.com Helps Governments Find Technology

December 10, 2010

reprint from a article on yet2.com published here: http://govpro.com/technology/content/online-technology-marketplace-20101209/

Governments are key drivers of product innovation. Funding from the American Recovery and Reinvestment Act of 2009 (ARRA), for instance, is helping governments try out innovative products on infrastructure projects, such as advanced materials for pavement rehabilitation and improved sensors for smart electric grids, reports Popular Mechanics.

Boston-based yet2.com, a company that operates an online technology marketplace and provides intellectual property consulting and licensing services, has assisted governments in finding innovative products.

Photo of Tim Bernstein, yet2.com's chief operating officerTim Bernstein

“We’ve done several searches on behalf of government organizations — everything from anti-graffiti technologies for municipal transportation departments to fairly advanced military applications for the federal military,” says Tim Bernstein, yet2.com’s chief operating officer. Read the rest of this entry »

1 Comment | news release, open innovation, yet2.com | Tagged: , , , , , | Permalink
Posted by bendupont

yet2Ventures Portfolio Company, A-Cube, Signs Drug Discovery Deal with Wakunaga Pharmaceuticals

December 7, 2010

A-CUBE Inc. and Wakunaga Pharmaceutical Co., Ltd. Announce Agreement on a Monoclonal Therapeutic Antibody
BELMONT, Calif., Dec. 7, 2010 (GLOBE NEWSWIRE) — A-CUBE Inc. (“A-CUBE”) today announced that it has signed a Material Transfer Agreement (MTA) and Exclusive Option Agreement for two groups of therapeutic monoclonals to the oncogene c-MET for treating cancer with Wakunaga Pharmaceutical Co., Ltd. (“WAKUNAGA”) of Osaka, Japan. Under the agreement, A-CUBE will supply lead candidate monoclonal antibodies that were predicted by Rational In Silico Algorithm on c-MET to WAKUNAGA.

WAKUNAGA will develop and validate animal models of various cancers using standard-of-care treatments, as well as develop and validate bioanalytical assays. At this point, the in vivo therapeutic potential of the two sets of monoclonals will be evaluated by WAKUNAGA. WAKUNAGA has the exclusive rights to conduct this evaluation in cancer models, and to negotiate for, and enter into exclusive collaborative research agreement with A-CUBE during a six month period following the experimental evaluation. Financial terms of the agreement were not disclosed.

“We are very pleased with this agreement with WAKUNAGA who have state-of-the art R&D facilities and expertise,” said Nobu Ota PhD, Founder and President of A-CUBE. “c-MET is a strong molecular target for cancer treatment.” Dr. Ota added, “WAKUNAGA is an excellent partner for these studies, and we have developed a strong relationship between our teams.”

Read the rest of this entry »

Leave a Comment » | news release, Venture capital, yet2.com, yet2Ventures | Tagged: , , , , | Permalink
Posted by bendupont

Electro Petroleum – Positive Results in Key Oil Production Test

November 15, 2010

Electro Petroleum (EPI) hired yet2.com 3 years ago.  We were so impressed with them that yet2Ventures invested.  Now EPI has investors, route to market partners, customers and is seeing real success turning dormant oils wells into productive ones.

How did this happen?

The Market

2/3 of the world’s heavy oil is to viscous to pump.  In fact there is more oil in the Canadian Oil Sands than all of the Middle East combined.  The problem is that it’s to heavy to pump.  The technology of choice was to ‘steam’ a well, meaning pump steam down a well, then pump up the oil/water mixture.  However this requires a lot of energy to steam water and to pump it down the well.  Steam condenses below about 2,000 feet, so in addition to all of the other major drawbacks, this approach doesn’t work when the oil is deep.

The Technology

Electro Petroleum uses a patented technology called EEOR – Electrically Enhanced Oil RecoverySM.  The electrical field upgrades the heavy crude through an electro-chemical process, mobilizes it through electro-kinetics, and heats it through joule or resistance heating .  Here’s a neat explanation of the technology. with a video.

What does all of this cost?  $4/barrel.

The Solution

What did yet2.com do?  We worked closely with the CEO of Electro Petroleum, Phil Bell.  We introduced him to Fortune 500 companies to help vet the technology.  We found capital sources to invest.  We found oil fields who wanted to be customers, like Deloro.  After all of this, we invested too.

Now Elecro Petroleum has wells producing that were abandoned.  The first is owned by Deloro, and it’s producing more than 15 barrel per day.  Other wells are in the process and looking very positive.

The Passion

We love helping entrepreneurs like Phil Bell, commercialize their technology.  We love helping entrepreneurs find; partners, customers, capital and people.  If you have an impressive technology we’ll love helping you too.

Read the rest of this entry »

Leave a Comment » | Clean Tech, future trends, news release, Venture capital, yet2.com, yet2Ventures | Tagged: , , , , , , , | Permalink
Posted by bendupont

« Previous Entries
Follow

Get every new post delivered to your Inbox.